| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |